Entod Pharma Gets Green Light for India’s First Eye Drops to Ease Age-Related Vision Problems

Entod Pharmaceuticals, a Mumbai-based company, has received approval from India’s Drug Controller General (DCGI) to market a new eye drop called PresVu, designed to treat presbyopia. This common vision problem affects people over 40 and makes it hard to see things up close.

Entod announced on September 3 that it plans to launch PresVu in the Indian market in the first week of October. The approval comes after a recommendation from the Central Drugs Standard Control Organisation’s (CDSCO) expert committee.

PresVu is the first eye drop in India made specifically to reduce the need for reading glasses for people with presbyopia. Entod’s CEO, Nikkhil K Masurkar, said this approval is a big step in improving eye care in India, offering millions of people more freedom from glasses.

Globally, around 1.09 to 1.8 billion people are estimated to suffer from presbyopia, a natural result of aging that makes it harder for the eyes to focus on nearby objects.

Masurkar mentioned that Entod plans to focus on meeting demand in India and emerging markets like Africa and Southeast Asia. The company also aims to innovate new products in India and then license them out to the US market, where they currently have no presence.

Entod is also committed to providing affordable medicines to countries that lack access, especially in Africa. The company, which manufactures its products in Maharashtra, focuses on treatments for ENT, eye care, and skin conditions. In the future, they may explore the mental health sector, which Masurkar believes has great potential in India.